The Rosen Law Firm, a global investor rights law firm, announced a September 22, 2025, deadline for investors in Replimune Group, Inc. (NASDAQ: REPL) to file as lead plaintiff in a class action lawsuit. The firm initiated the suit on behalf of investors who purchased Replimune securities between November 22, 2024, and July 21, 2025.
The lawsuit alleges that Replimune made false and misleading statements during this period. Specifically, the complaint contends that the company overstated the prospects of its IGNYTE trial, failing to disclose material issues that ultimately led the U.S. Food and Drug Administration (FDA) to deem the trial inadequate.
This alleged misrepresentation, the lawsuit argues, caused investors to suffer financial losses when the truth became public. Rosen Law Firm contends that Replimune‘s statements concerning its business, operations, and future prospects were materially false and lacked a reasonable basis.
Rosen Law Firm encourages investors to carefully consider their options and seek legal counsel with experience in securities class action litigation. The firm highlighted its extensive experience and successes in representing investors in similar cases. They emphasized their track record, including a significant settlement achieved against a Chinese company and consistent high rankings in securities class action settlements.
The firm’s achievements include securing over $438 million for investors in 2019 alone. Laurence Rosen, the firm’s founding partner, was recognized as a Titan of the Plaintiffs’ Bar by Law360 in 2020. Many of the firm’s attorneys have received recognition from prominent legal publications.
Investors who purchased Replimune securities during the specified period are urged to contact Rosen Law Firm before the September 22, 2025 deadline to learn more about their rights and potential participation in the class action. The firm emphasizes that participation as lead plaintiff is not a prerequisite for sharing in any potential recovery. Investors can contact Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com. The firm’s New York office is located at 275 Madison Avenue, 40th Floor, New York, NY 10016.
It is important to note that no class has been certified yet. Investors are free to choose their own legal representation or remain absent class members. Past results do not guarantee future outcomes.
Related
